Subtype
Benign Prostatic Hyperplasia
CI-CAN-00007306BPHExplore in graph →
Non-malignant12 active trials
- NCIt
- C2897
Loading cancer entity…
Subtype
CI-CAN-00007306BPHExplore in graph →
Clinical trials
65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04693507 | Teverelix Evaluated in Advanced Prostate Cancer(TEACh) | completed | Phase 2 | 50 | Antev Ltd.INDUSTRY | 1 | Jul 23, 2024 | clinicaltrials |
| NCT00596011 | Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia | completed | Phase 2 | 97 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 4, 2019 | clinicaltrials |
| NCT01678313 | Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels | completed | Phase 2 | 140 | Buddhist Tzu Chi General HospitalOTHER | 1 | Jul 15, 2014 | clinicaltrials |
| NCT01218243 | An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia |
Data updated 22 days agoSource updated Jul 23, 2024source: clinicaltrials
| completed |
| Phase 2 |
| 100 |
| Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER |
| 1 |
| May 27, 2013 |
| clinicaltrials |